Please login to the form below
New Accounts, Jan - Mar, 2007
New accounts
The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period January to March 2007 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets. To submit an entry for New Accounts, email new_accounts@pmlive.com
| ADVERTISING AGENCIES | |||
| Client | Product | Therapeutic area | Winning agency |
|---|---|---|---|
| Alliance Pharmaceuticals | Isprelor | Obstetrics and gynaecology | Hanson Zandi |
| Healthcare Brands International | Sambucol | Immunology | Woolley Pau |
| Merck-Serono | Educational and professional development | Multiple sclerosis | Roundhouse HealthAd |
| Merial | Rabisin | Rabies vaccine | Roundhouse HealthAd |
| Merz | Xeomin and Belotero | Dermatology | Roundhouse HealthAd |
| Roche Products | Herceptin, Avastin | Oncology | MSA Market Media |
| Roche Products | Neorecormon | Nephrology | MSA Market Media |
| Roche Products | MabThera | Rheumatoid arthritis | MSA Market Media |
| Roche Products | Xenical | Obesity | MSA Market Media |
| Roche Products | Tamiflu | Influenza | MSA Market Media |
| Sanofi Pasteur MSD | Pneumovax II | Pneumococcal vaccine | Woolley Pau |
| SD Healthcare | Myiasert | Ophthalmology | Courts Design |
| Teva UK | Clozapine | Anti-psychotic | Courts Design |
| Wyeth | Anya | Oral contraceptives | Creative Lynx |
| Wyeth | DVS - VMS | Menopause | Creative Lynx |
| ZLB Behring (Global) | Haemate P | Haematology | Hanson Zandi |
| ZLB Behring (Global) | Rhophylac | Obstetrics and gynaecology | Hanson Zandi |
| PR AND MED ED | |||
| Client | Product | Therapeutic area | Winning agency |
|---|---|---|---|
| Alliance Pharmaceuticals | Labour induction website | Obstetrics and gynaecology | Hanson Zandi |
| Baxter | Brevibloc | Cardiovascular | Wave Healthcare Communications |
| Boehringer Ingelheim | New product | Anti-coagulation | Wave Healthcare Communications |
| European Coalition of Positive People | Integrated communications programme | HIV/AIDS and Hepatitis C | De Facto Communications |
| Ferring International | Euflexxa KOL development | Orthopaedics | Helen Lawn & Associates |
| Ferring International | Zomacton | Endocrinology | Helen Lawn & Associates |
| Ferring Pharmaceuticals | DesmoMelt | Urology | Helen Lawn & Associates |
| Ferring Pharmaceuticals | VSL 3 | Gastroenterology | Helen Lawn & Associates |
| Genzyme | Thyrogen | Endocrinology/oncology | Medaxial |
| McNeil | Immodium | Diarrhoea | Spink Consumer Relations |
| Merck Pharmaceuticals | Erbitux and Uftoral | Colorectal cancer | Red Door Communications |
| Merck-Serono | Easypod | Growth hormone injection device | LeapFrog Medical |
| MˆInlycke Healthcare | Patient awareness initiative | Infection control | hsdcommunications |
| MSD | New product | HIV | Wave Healthcare Communications |
| Nelsons | Rescue remedy | Homeopathy | Pegasus PR |
| Novartis | Aclasta | Paget's Disease | LeapFrog Medical |
| Novartis | N/A | Cardiovascular, diabetes and neuroscience | Just:: |
| sanofi-aventis | N/A | VTE | Medaxial |
| Schering Health Care | N/A | Oncology | Medaxial |
| Schering Health Care | Zevalin | Oncology | Medaxial |
| Shire Pharmaceuticals | Reminyl | Alzheimer's disease | hsdcommunications |
| Stiefel Laboratories | Oilatum | Skin conditions | McCann Erickson Communications |
Share
Related Hub content
COVID-19 Updates and Daily News
Featured jobs
- Trevena gets second go at FDA approval for pain drug
- How will the events and exhibitions industry change post-Coronavirus?
- A new era for patient services?
- UK government and GSK/Sanofi sign COVID-19 vaccine supply deal
- Amgen adds Otezla to the COVID-19 candidate list
- COVID-19 round-up: WHO pulls hydroxychloroquine study, UK restricts dexamethasone exports, and more
- Live Webinar: Using Health IT to Improve the Healthcare System
- J&J’s COVID-19 vaccine generates positive pre-clinical results
- Gilead’s top-line slips 10% as demand for HIV/hepatitis C drugs drops
- NICE recommends Merck/Pfizer’s PD-L1 inhibitor Bavencio for kidney cancer
- Roche’s Tecentriq combo scores FDA approval for melanoma
- Covid-19 drives change in long-term conditions management
PMHub
Viseven
Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...
Latest intelligence
- Covid-19 drives change in long-term conditions management
- Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore how patients are being empowered to manage their conditions at home...
- The importance of health literacy in patient recruitment materials
- Have you ever read something that instantly made you want to read on? Or have you begun to read something, and eventually given up because it didn’t resonate with you?...
- Secondary effects of COVID-19 on the healthcare system and patients
- We are getting to the point where we need to start considering the long-term effects on the healthcare system when making decisions....
Quick links
Infographics
